medigraphic.com

2013, Number 1

<< Back

Enf Infec Microbiol 2013; 33 (1)

A second episode of chickenpox in an immunocompetent adult. Case report

Suárez CM, Reyes BDA, Cortés FAÁ

Language: Spanish
References: 30
Page: 44-47
PDF size: 122.95 Kb.


ABSTRACT

We present a case report of a second case of chickenpox in an immunocompetent adult. The patient is a nurse in the area of Pediatric Critical Care Medicine in a High Specialty Hospital of Mexico City. The clinical picture began with malaise and slight hyaline rhinorrhea, adding, 48 hours later, maculopapular lesions predominating in the face, neck and lower torso. Two pearly vesicular lesions were observed in the upper back. When questioned, she reported a history of close contact with two cases of chickenpox. The diagnosis was confirmed in the patient, based on signs and symptoms of the clinical profile, the epidemiological history of contact, and the serological test for antibodies to varicella-zoster virus (VZV) by enzyme immunosorbent assay (ELISA).


REFERENCES

  1. 1.-Arvin A. “Varicella-zoster virus”. Clin Microbiol Rev 1996; 9: 361-381.

  2. 2.-CDC. “Varicella”. En Atkinson W. (Ed.) Epidemiology and Prevention of Vaccine-Preventable Diseases. Atlanta, GA: Centers for Disease Control and Prevention, 2005:159-175.

  3. 3.-Gershon AA, Steinberg SP, Gelb L. “Clinical reinfection with varicella-zoster virus”. J Infect Dis 1984; 149: 137- 142.

  4. 4.-Gelb LD. “Varicella zoster virus”. En Fields BN, Knipe DM, et al. (Eds) Virology. 2a ed. Nueva York: Raven Press Ltd,1990: 2011-2054.

  5. 5.-Sadzot-Delvaux C, Debrus S, Nikkels AF, Piette J, Rentier B. “Varicella-zoster virus latency in the adult rat is a useful model for human latent infection”. Neurology 1995; 45: 18-20.

  6. 6.-Mahalingham R, Wellsh M, Cohrs R, Debrus S, Piette J, Rentier B, et al. “Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons”. Proc Natl Acad Sci USA 1996; 93: 2122.

  7. 7.-Gilden DH, Mahalingam R, Dueland AM, Cohrs R. “Herpes zoster: pathogenesis and latency”. Prog Med Virol 1992; 39: 19-75.

  8. 8.-McCrary ML, Severson J, Tyring SK. “Varicella zoster virus”. J Am Acad Dermatol 1999; 41: 1-14.

  9. 9.-Guess HA, Broughton DD, Melton LJ, et al. “Population- based studies of varicella complications”. Pediatrics 1986; 78: 723-727

  10. 10.-Wallace MR, Bowler WA, Murray NB, et al. “Treatment of adult varicella with oral acyclovir: a randomised, placebo-controlled trial”. Ann Intern Med 1992; 117: 358-363.

  11. 11.-Feder HM. “Treatment of adult chickenpox with oral acyclovir”. Arch Intern Med 1990; 150: 2061-2065.

  12. 12.-Weber DM, Pellecchia JA. “Varicella pneumonia”. JAMA 1965; 192: 572-573

  13. 13.-Heskel NS, Hanifin JM. “Recurrent herpes zoster: an unproved entity?” J Am Acad Dermatol 1984; 10: 486-490.

  14. 14.-Von Seidlein L, Gillette SG, Bryson Y, Frederick T, Mascola L, Church J, et al. “Frequent recurrence and persistence of varicellazoster virus infections in children infected with human immunodeficiency virus type 1”. J Pediatr 1996; 128: 52-57.

  15. 15.-Satoh N, Abe T, Nakajima A, Sakuragi S. “Recurrent varicella-zoster virus retinitis in a patient treated with systemic corticosteroids”. Ocul Immunol Inflamm 1998; 6: 185.

  16. 16.-Nikkels AF. Piérard GE. “Shingles developing within recent surgical scars”. J Am Acad Dermatol 1999; 41: 309-311.

  17. 17.-Srugo I, Israele V, Wittek AE, Courville T, Vimal VM, Brunell PA. “Clinical manifestations of varicella-zoster virus infections in human immunodeficiency virus-infected children”. Am J Dis Child 1993; 147: 742-745.

  18. 18.-Suwabe H, Yabe H, Tsutsumi Y. “Relapsing hemorrhagic varicella”. Pathol Int 1996; 46: 605-609.

  19. 19.-Acheson DW, Leen CL, Tariq WU, Mandal BK. “Severe and recurrent varicella-zoster virus infection in a patient with the acquired immune deficiency syndrome”. J Infect 1988; 16: 193-197.

  20. 20.-Pitche P, Gbadoe AE, Tidjani O, Tchangai-Walla K. “Recurrent varicella and HIV infection: apropos of 10 cases seen in Lome”. Med Trop (Mars) 1997; 57: 65-67.

  21. 21.-Baxter JD, DiNubile MJ. “Relapsing chickenpox in a young man with non-Hodgkin’s lymphoma”. Clin Infect Dis 1994; 18: 785-788.

  22. 22.-Selbst RG, Selhorst JB, Harbison JW, et al. “Parainfectious optic neuritis”. Arch Neurol 1983: 40: 347-350.

  23. 23.-Galbussera A, Tagliabue E, Frigo M, Apale P, Ferrarese C, Appollonio I. “Isolated bilateral anterior optic neuritis following chickenpox in an immunocompetent adult”. Neurol Sci 2006: 27: 278-280.

  24. 24.-Erlich KS. “Management of herpes simplex and varicella- zoster virus infections.” West j Med 1997 Mar; 166: 211-215.

  25. 25.-Chih-Hung Ku, Yu-Tien Liu, David C. Christiani. “Case Report: Occupationally Related Recurrent Varicella (Chickenpox) in a Hospital Nurse”. Environmental Health Perspectives, October 2005: 113-110.

  26. 26.-Jumaan A, Hughes H, Schmid S, Galil K, Plott K, Zimmerman L, et al. “Varicella”. En Wharton M, Hughes H, Reilly M. (Eds.) Manual for the Surveillance of Vaccine- Preventable Diseases. Atlanta, GA: Centers for Disease Control and Prevention, 2002: 11-21.

  27. 27.-Marin M, Güris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). “Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).” MMWR Recomm Rep 2007: 56(RR-4): 1-40.

  28. 28.-Atkinson W, Wolfe S, Hamborsky J, McIntyre L. (Eds.) “Centers for Disease Control and Prevention”. Epidemiology and Prevention of Vaccine-Preventable Diseases. 11th ed. Washington, DC: Public Health Foundation, 2009.

  29. 29.-Weber D, Rutala W, Parham C. “Impact and costs of varicella prevention in a university hospital”. Am J Public Health 1988; 78: 19-23.

  30. 30.-Prevención, diagnóstico y tratamiento de la varicela infantil en el primer nivel de atención. México: Secretaría de Salud; 2008




2020     |     www.medigraphic.com